Capabilities
Repurposing & Reformulation
Identify new opportunities from existing pharmaceutical assets — new indications, reformulations, and patent-cliff strategies — with scientific and commercial rigor.
The challenge
The cost and timeline of de novo drug development make it one of the most capital-intensive endeavors in any industry. Yet many organizations hold existing assets — approved products, late-stage compounds, and proprietary formulation platforms — whose full value has never been realized.
Tarseva helps organizations systematically identify, evaluate, and pursue repurposing and reformulation opportunities — turning existing assets into new sources of patient value and commercial return.
What we do
Services in this capability
Asset Opportunity Assessment
Systematically evaluate your existing asset portfolio for repurposing and reformulation potential — identifying new indications, patient populations, and formulation strategies with the strongest scientific and commercial rationale.
New Indication Strategy
Develop evidence-based strategies for pursuing new indications — from target identification and mechanism analysis through clinical development planning and regulatory pathway assessment.
Reformulation Development Planning
Identify and evaluate reformulation opportunities — extended release, combination products, novel delivery systems, and pediatric formulations — with integrated scientific, regulatory, and commercial analysis.
Patent Cliff Strategy
Develop strategies to manage patent expiry and generic competition — through lifecycle extensions, authorized generics, next-generation formulations, and portfolio repositioning.
Licensing & Partnership Evaluation
Evaluate in-licensing and partnership opportunities for repurposing assets — with scientific due diligence, commercial modeling, and deal structure analysis.
Regulatory Pathway Planning
Map the regulatory pathway for repurposing and reformulation programs — identifying the most efficient route to approval and the evidence requirements at each stage.
What you gain
Outcomes that matter
New revenue streams
Existing assets generating new commercial value
Reduced development risk
Known safety profiles accelerating new programs
Extended patent protection
Lifecycle strategies defending market position
Patient access
New formulations reaching underserved populations
Ready to unlock the value in your existing assets?
Talk to Tarseva about how we can help you identify and pursue repurposing and reformulation opportunities.